| PUBCHEM ID |
91667671
|
| UNII |
K0VHF4KL3N
|
| Preferred Term |
20-HYDROXY METHYLPREDNISOLONE, (20S)-
|
| CAS |
387-66-6
|
| INCHIKEY |
GXALFBTWPDTDIR-CJXIPBSFSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
C[C@@H](C[C@@H]([C@H](CC1)[C@](C)(C[C@@H]2O)[C@]1([C@H](CO)O)O)[C@H]2[C@@]1(C)C=C2)C1=CC2=O
|
| Total Surface Area |
265,67
|
| Relative PSA |
0,24632
|
| TPSA |
97,99
|
| cLogS |
-3,067
|
| MW |
376,491
|
| cLogP |
1,4419
|
| H-Acceptors |
5
|
| H-Donors |
4
|
| Ro5 violations |
0
|
| Druglikeness |
2,7232
|
| DrugScore |
0,812483465315894
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Blood-Brain Barrier |
BBB+
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,5793
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Non-inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Mitochondria
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
0,9673
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
1,06
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,2859
|
| Carcinogenicity (Three-class) |
Non-required
|
